Current obesity management includes pharmacotherapy, metabolic bariatric surgery, and lifestyle management, each capable of clinically significant weight loss, yet each undermined by the same challenge: maintenance. Roughly two-thirds of patients regain weight within a year of stopping incretin mimetic therapies, 20–30% regain after surgery, and fewer than one in five sustain a 10% reduction through lifestyle measures alone. This maintenance of weight regain is biologically and psychologically driven. Body fat is actively defended by the brain, and metabolic adaptation heightens hunger while lowering energy expenditure.
This presentation positions clinical hypnotherapy as a missing component of contemporary obesity care. The neuroscience of habit, involving the dopamine-driven basal ganglia loop and the prefrontal cortex, explains why willpower is often insufficient and how hypnosis can disrupt and rewire subconscious habit and reward circuits during periods of neural malleability. The findings of brain neuroimaging of the default mode, salience, and executive networks, together with randomised clinical trial evidence, support the efficacy of hypnosis for weight loss and lasting behaviour change.
A case study illustrates hypnotherapy's impact in a complex patient with chronic pain, high opioid burden, and negative self-image.
Clinical hypnotherapy is increasingly recognised as an evidence-based, non-pharmacological therapy with a sound neurobiological basis. It is inexpensive, safe, effective and requires no special equipment. This case discussion demonstrates the integration of clinical hypnotherapy with other lifestyle measures, pharmacotherapy and surgery to support and close the weight loss maintenance gap.